Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 10—October 2008
Research

Prophylaxis after Exposure to Coxiella burnetii

Claire E. MoodieComments to Author , Herbert A. Thompson, Martin I. Meltzer, and David L. Swerdlow
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA;

Main Article

Table 3

Total medical cases averted because of postexposure prophylaxis*

Population No. cases averted
General population
All cases of illness 39,990
Severe illness 10,650
Deaths
480
High-risk population
All cases of illness 39,990
Severe illness 29,510
Deaths
3,538
Pregnant women†
All cases of illness 66,210
Severe illness 53,300
Deaths 22,394

*Accounting for best estimate drug-related adverse events, 82% drug efficacy, and 100% exposure.
†Includes the outcome of the unborn child.

Main Article

Page created: July 13, 2010
Page updated: July 13, 2010
Page reviewed: July 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external